Lilly(Eli) & Overview
Lilly(Eli) & Target Price
Analysts' 12-month price predictions for LLY.
Share Price
$737.2
Average Target Price
$717.50
2.7% downside
2.7% downside2 analysts in the last 4 months
High: $900 | Low: $535
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-18 | BMO CapitalEvan David Seigerman | $900 |  22.1% upside |  |
| 2024-02-06 | Deutsche BankJames Shin | $535 | 27.4% downside | |
| 2023-12-28 | CitigroupAndrew Baum | $675 | 8.4% downside | |
| 2023-10-11 | Morgan StanleyDavid Phung | $673 | 8.7% downside | |
| 2023-08-09 | Morgan StanleyTerence Flynn | $617 | 16.3% downside | |
| 2023-08-09 | Cantor FitzgeraldLouise Chen | $630 | 14.5% downside | |
| 2023-02-03 | Morgan Stanley | $455 | 38.3% downside | |
| 2023-02-03 | Wells Fargo | $360 | 51.2% downside | |
| 2023-01-03 | Barclays | $400 | 45.7% downside | |
| 2022-12-17 | Cowen & Co.Cowen Cowen | $430 | 41.7% downside | |
| 2022-12-16 | Leerink Partners | $410 | 44.4% downside | |
| 2022-12-15 | UBS | $420 | 43% downside | |
| 2022-12-14 | Morgan Stanley | $440 | 40.3% downside | |
| 2022-12-08 | Wells Fargo | $375 | 49.1% downside | |
| 2022-12-07 | Guggenheim | $401 | 45.6% downside | |
| 2022-12-06 | Credit Suisse | $400 | 45.7% downside | |
| 2022-12-06 | Morgan Stanley | $446 | 39.5% downside | |
| 2022-11-18 | Credit Suisse | $395 | 46.4% downside | |
| 2022-11-17 | Morgan Stanley | $436 | 40.9% downside | |
| 2022-10-02 | UBSColin Bristow Bristow | $336 | 54.4% downside | |
| 2022-09-22 | UBSNavin Jacob | $363 | 50.8% downside | |
| 2022-09-07 | Morgan Stanley | $412 | 44.1% downside | |
| 2022-09-06 | BMO Capital | $396 | 46.3% downside | |
| 2022-07-08 | Morgan Stanley | $395 | 46.4% downside | |
| 2022-07-07 | Barclays | $355 | 51.8% downside | |
| 2022-06-01 | J.P. Morgan | $355 | 51.8% downside | |
| 2022-05-23 | Leerink PartnersDavid Risinger | $341 | 53.7% downside | |
| 2022-05-09 | UBSNavin Jacob | $293 | 60.3% downside | |
| 2022-05-08 | BMO CapitalEvan David Seigerman | $358 | 51.4% downside | |
| 2022-05-03 | Mizuho SecuritiesVamil Divan | $356 | 51.7% downside | |
| 2022-04-30 | Wells FargoMohit Bansal | $305 | 58.6% downside | |
| 2022-04-29 | Morgan Stanley | $369 | 49.9% downside | |
| 2022-04-11 | Morgan StanleyTerence Flynn | $364 | 50.6% downside | |
| 2022-03-26 | Bank of America SecuritiesGeoff Meacham | $315 | 57.3% downside | |
| 2022-02-06 | Morgan StanleyMatthew Harrison | $265 | 64.1% downside | |
| 2022-01-30 | Cantor FitzgeraldLouise Chen | $335 | 54.6% downside | |
| 2022-01-04 | Wells FargoMohit Bansal | $280 | 62% downside | |
| 2022-01-03 | BernsteinAaron Gal | $300 | 59.3% downside | |
| 2021-12-20 | BarclaysCarter Gould | $325 | 55.9% downside | |
| 2021-12-17 | Goldman SachsChris Shibutani | $236 | 68% downside | |
| 2021-12-16 | J.P. MorganChris Schott | $325 | 55.9% downside | |
| 2021-12-07 | CitigroupAndrew Baum | $265 | 64.1% downside | |
| 2021-11-29 | UBSNavin Jacob | $267 | 63.8% downside | |
| 2021-09-21 | GuggenheimSeamus Fernandez | $266 | 63.9% downside | |
| 2021-08-30 | Cowen & Co.Steve Scala | $300 | 59.3% downside | |
| 2021-08-09 | Argus ResearchDavid Toung | $300 | 59.3% downside | |